Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation. 1997

M Podestà, and G Piaggio, and F Frassoni, and A Pitto, and N Mordini, and S Bregante, and A Valeriani, and A Bacigalupo
Divisione Ematologia, Ospedale San Martino, Genova, Italy.

Allogeneic bone marrow transplant recipients maintain normal peripheral blood counts long term, suggesting durable support from engrafted stem cells. In order to investigate late hemopoietic reconstitution at the level of committed and early progenitors (LTC-IC), we studied 64 long-term survivors at a median interval of 6 years (range: 2-20) after allogeneic bone marrow transplant. CFU-GM and BFU-E numbers did not differ from normal controls; CFU-GEMM were found to be significantly decreased (1.2 +/- 0.2/10(5) vs 3.1 +/- 0.4, P = 0.001). The most remarkable defect was however, the low frequency of LTC-IC (3.2 +/- 0.6/10(6) vs 54.2 +/- 9.3, P = 0.0001) that did not improve with time and did not correlate with phase of the disease, conditioning regimen, CMV infections or GVHD. Number of infused cells and CFU-GM content of marrow grafts did not seem to influence the number of LTC-IC. This study documents a significantly reduced number of early progenitors in BMT patients despite normal numbers of committed progenitors and normal peripheral blood counts. This finding may suggest a permanent reduction of the stem cell reservoir after allogeneic bone marrow transplantation.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay
D005260 Female Females
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

M Podestà, and G Piaggio, and F Frassoni, and A Pitto, and N Mordini, and S Bregante, and A Valeriani, and A Bacigalupo
October 1989, Histopathology,
M Podestà, and G Piaggio, and F Frassoni, and A Pitto, and N Mordini, and S Bregante, and A Valeriani, and A Bacigalupo
December 1988, Blood,
M Podestà, and G Piaggio, and F Frassoni, and A Pitto, and N Mordini, and S Bregante, and A Valeriani, and A Bacigalupo
June 1985, The Tokai journal of experimental and clinical medicine,
M Podestà, and G Piaggio, and F Frassoni, and A Pitto, and N Mordini, and S Bregante, and A Valeriani, and A Bacigalupo
May 1990, Journal of clinical pathology,
M Podestà, and G Piaggio, and F Frassoni, and A Pitto, and N Mordini, and S Bregante, and A Valeriani, and A Bacigalupo
January 2005, Blood,
M Podestà, and G Piaggio, and F Frassoni, and A Pitto, and N Mordini, and S Bregante, and A Valeriani, and A Bacigalupo
January 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
M Podestà, and G Piaggio, and F Frassoni, and A Pitto, and N Mordini, and S Bregante, and A Valeriani, and A Bacigalupo
April 2000, Transplantation,
M Podestà, and G Piaggio, and F Frassoni, and A Pitto, and N Mordini, and S Bregante, and A Valeriani, and A Bacigalupo
June 2001, Bone marrow transplantation,
M Podestà, and G Piaggio, and F Frassoni, and A Pitto, and N Mordini, and S Bregante, and A Valeriani, and A Bacigalupo
September 2011, Blood,
M Podestà, and G Piaggio, and F Frassoni, and A Pitto, and N Mordini, and S Bregante, and A Valeriani, and A Bacigalupo
May 1990, Blood,
Copied contents to your clipboard!